Search

everythinglearnresearchcommunity

for

Search:↓

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Severe acne in a young girl may indicate underlying hormonal issues.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Follicle Stimulating Hormone is important for fertility.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The photographic method for measuring facial hair density is reliable and valid but needs further testing on different hair densities and skin colors.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

The document's conclusion cannot be provided because the document is not readable or understandable.

Women with PCOS are more likely to experience depression and have a negative body image compared to women without PCOS.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Melatonin may help treat PCOS symptoms in rats.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

An older woman had false beliefs after taking a depression medication, which stopped when she stopped the medication.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.